DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Ochi S, Takeyama M, Shima M, Nogami K.
Plasma-derived factors VIIa and X mixtures (Byclot®) significantly improve impairment of coagulant potential ex vivo in plasmas from acquired hemophilia A patients.
Int J Hematol 2020;
111 (06) 779-785
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.